Design and bio-evaluation of indole derivatives as potent Kv1.5 inhibitors

被引:22
|
作者
Guo, Xiaoke [1 ,2 ]
Yang, Qian [1 ,2 ]
Xu, Jing [4 ]
Zhang, Li [4 ]
Chu, Hongxi [1 ,3 ]
Yu, Peng [4 ]
Zhu, Yingying [4 ]
Wei, Jinglian [3 ]
Chen, Weilin [3 ]
Zhang, Yaozhong [3 ]
Zhang, Xiaojin [1 ]
Sun, Haopeng [1 ,2 ,3 ]
Tang, Yiqun [4 ]
You, Qidong [1 ,2 ]
机构
[1] China Pharmaceut Univ, Jiang Su Key Lab Drug Design & Optimizat, Nanjing 210009, Jiangsu, Peoples R China
[2] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China
[3] China Pharmaceut Univ, Sch Pharm, Dept Med Chem, Nanjing 210009, Jiangsu, Peoples R China
[4] China Pharmaceut Univ, Res Div Pharmacol, Nanjing 210009, Jiangsu, Peoples R China
关键词
Atrial fibrillation (AF); Kv1.5; Indole derivatives; Structure-activity relationship (SAR); ATRIAL-FIBRILLATION THERAPY; ANTIARRHYTHMIC-DRUG THERAPY; HERG POTASSIUM CHANNELS; VENTRICULAR MYOCYTES; I-KUR; BLOCKERS; AGENT; STRATEGIES; MANAGEMENT; AMIDES;
D O I
10.1016/j.bmc.2013.08.041
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Atrial fibrillation (AF) is one of the common arrhythmias that threaten human health. Kv1.5 potassium channel is reported as an efficacious and safe target for the treatment of AF. In this paper, we designed and synthesized three series of compounds through modifying the lead compound RH01617 that was screened out by the pharmacophore model we reported earlier. All of the compounds were evaluated by the whole-patch lamp technology and most of them possessed potent inhibitory activities against Kv1.5. Compounds IIIi and IIIl were evaluated for the target selectivity as well as the pharmacodynamic effects in an isolated rat model. Due to the promising pharmacological behavior, compound IIIl deserves further pharmacodynamic and pharmacokinetic evaluations. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6466 / 6476
页数:11
相关论文
共 50 条
  • [1] Design, synthesis and evaluation of phenethylaminoheterocycles as Kv1.5 inhibitors
    Johnson, James A.
    Xu, Ningning
    Jeon, Yoon
    Finlay, Heather J.
    Kover, Alexander
    Conder, Mary L.
    Sun, Huabin
    Li, Danshi
    Levesque, Paul
    Hsueh, Mei-Mann
    Harper, Timothy W.
    Wexler, Ruth R.
    Lloyd, John
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (14) : 3018 - 3022
  • [2] Design, synthesis, and biological evaluation of arylmethylpiperidines as Kv1.5 potassium channel inhibitors
    Zhao, Lingyue
    Yang, Qian
    Tang, Yiqun
    You, Qidong
    Guo, Xiaoke
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2022, 37 (01) : 462 - 471
  • [3] Design of a Potent and Selective Small Molecule Kv1.5 Blocker
    Sankaranarayanan, Ananthakrishnan
    BIOPHYSICAL JOURNAL, 2010, 98 (03) : 709A - 709A
  • [4] Lactam sulfonamides as potent inhibitors of the Kv1.5 potassium ion channel
    Olsson, Roine I.
    Jacobson, Ingemar
    Iliefski, Tommy
    Bostrom, Jonas
    Davidsson, Ojvind
    Fjellstrom, Ola
    Bjore, Annika
    Olsson, Christina
    Sundell, Johan
    Gran, Ulrik
    Gyll, Jonna
    Malmberg, Jesper
    Hidestal, Olle
    Emtenas, Hans
    Svensson, Tor
    Yuan, Zhong-Qing
    Strandlund, Gert
    Astrand, Annika
    Lindhardt, Emma
    Linhardt, Gunilla
    Forsstrom, Elin
    Hogberg, Agot
    Persson, Frida
    Andersson, Birgit
    Ronnborg, Anna
    Lofberg, Boel
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (05) : 1269 - 1273
  • [5] Dihydropyrazolopyrimidine Inhibitors of KV1.5 (IKur)
    Vaccaro, Wayne
    Huynh, Tram
    Lloyd, John
    Atwal, Karnail
    Finlay, Heather J.
    Levesque, Paul
    Conder, Mary Lee
    Jenkins-West, Tonya
    Shi, Hong
    Sun, Lucy
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (24) : 6381 - 6385
  • [6] Novel, potent inhibitors of cloned Kv1.5 potassium channels and human IKur
    Lagrutta, A
    Fermini, B
    Salata, J
    FASEB JOURNAL, 2004, 18 (05): : A1282 - A1282
  • [7] Design, modification, and bio-evaluation of salazinic acid derivatives
    Nguyen-Kim-Tuyen Pham
    Nguyen-Minh-An Tran
    Huy Truong Nguyen
    Duc-Dung Pham
    Thi-Quynh-Trang Nguyen
    Thi-Hong-Anh Nguyen
    Huu-Tri Nguyen
    Thanh-Hung Do
    Ngoc-Hong Nguyen
    Thuc-Huy Duong
    ARABIAN JOURNAL OF CHEMISTRY, 2022, 15 (01)
  • [8] Synthesis and evaluation of diphenylphosphinic amides and diphenylphosphine oxides as inhibitors of Kv1.5
    Olsson, Roine I.
    Jacobson, Ingemar
    Bostrom, Jonas
    Fex, Tomas
    Bjore, Annika
    Olsson, Christina
    Sundell, Johan
    Gran, Ulrik
    Ohrn, Anna
    Nordin, Andreas
    Gyll, Jonna
    Thorstensson, Maria
    Hayen, Ahlke
    Aplander, Karolina
    Hidestal, Olle
    Jiang, Fanyi
    Linhardt, Gunilla
    Forsstrom, Elin
    Collins, Teresa
    Sundqvist, Monika
    Lindhardt, Emma
    Astrand, Annika
    Lofberg, Boel
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (03) : 706 - 710
  • [9] Phenethylaminoheterocycles as Kv1.5 ion channel inhibitors
    Johnson, James A.
    Xu, Ningning
    Jeon, Yoon
    Finlay, Heather J.
    Kover, Alexander
    Li, Ling
    Sun, Huabin
    Li, Danshi
    Levesque, Paul
    Conder, Mary L.
    Hsueh, Mei-Mann
    Harper, Timothy W.
    Wexler, Ruth R.
    Lloyd, John
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [10] Pseudosaccharin amines as potent and selective KV1.5 blockers
    Lloyd, John
    Finlay, Heather J.
    Kover, Alexander
    Johnson, James
    Pi, Zulan
    Jiang, Ji
    Neels, James
    Cavallaro, Cullen
    Wexler, Ruth
    Conder, Mary Lee
    Shi, Hong
    Li, Danshi
    Sun, Huabin
    Chimalakonda, Anjaneya
    Huang, Christine
    Salvati, Mark
    Levesque, Paul
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (21) : 4983 - 4986